Samjin Pharm Capital Reinvestment Ratio
Samjin Pharm capital reinvestment ratio. Samjin Pharm (005500) has a Capital Reinvestment Ratio of 0.36x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩10.63 Billion) in capital expenditures (₩3.78 Billion). See Samjin Pharm (005500) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Samjin Pharm (2013–2024)
Capital reinvestment ratio of Samjin Pharm from 2013 to 2024. This chart tracks Samjin Pharm's Capital Reinvestment Ratio across 12 annual periods. See Samjin Pharm free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Samjin Pharm Capital Reinvestment Ratio by Year (2013–2024)
Samjin Pharm capital reinvestment ratio by year from 2013 to 2024. For the full cash flow conversion analysis, see Samjin Pharm operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.48x | ₩38.15 Billion | ₩18.34 Billion | ▼ -80.7% |
| 2023 | 2.49x | ₩8.33 Billion | ₩20.72 Billion | ▲ +21.1% |
| 2022 | 2.05x | ₩17.29 Billion | ₩35.50 Billion | ▼ -34.1% |
| 2021 | 3.11x | ₩23.97 Billion | ₩74.60 Billion | ▲ +142.7% |
| 2020 | 1.28x | ₩23.86 Billion | ₩30.60 Billion | ▲ +151.7% |
| 2019 | 0.51x | ₩23.63 Billion | ₩12.04 Billion | ▲ +86.1% |
| 2018 | 0.27x | ₩30.08 Billion | ₩8.24 Billion | ▲ +15.2% |
| 2017 | 0.24x | ₩37.28 Billion | ₩8.86 Billion | ▲ +48.3% |
| 2016 | 0.16x | ₩48.66 Billion | ₩7.80 Billion | ▼ -60.4% |
| 2015 | 0.40x | ₩18.94 Billion | ₩7.66 Billion | ▼ -1.8% |
| 2014 | 0.41x | ₩32.41 Billion | ₩13.35 Billion | ▼ -55.5% |
| 2013 | 0.93x | ₩7.37 Billion | ₩6.83 Billion | — |